Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11679103
Multi-targeting agents for Alzheimer's disease therapy
granted -
US 11679100
Methods of enhancing immunity
granted -
US 11674121
Platform for generating safe cell therapeutics
granted -
US 11674159
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 11673866
Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases
granted -
US 11667903
Tracking and manipulating cellular RNA via nuclear delivery of CRISPR/CAS9
granted -
US 11667920
Methods for treating brain injury
granted -
US 11666666
Methods and compositions for modifying a mutant dystrophin gene in a cell's genome
granted -
US 11666660
Glycan-dependent immunotherapeutic molecules
granted -
US 11666661
Methods and compounds for targeted autophagy
granted -
US 11667900
Compositions and methods for enhancing macrophage-mediated antibody guided cancer cell or tumor eradication
granted -
US 11666609
Methods of treating dog urinary tract infections
granted -
US 11666528
Drug implants containing enzalutamide and methods of use thereof
granted -
US 11661606
Mature plant transfection using carbon nanotubes
granted -
US 11660571
Microscale device and method for purification of radiopharmaceuticals
granted -
US 11661599
CRISPR-Cas based system for targeting single-stranded sequences
granted -
US 11654193
Cancer treatment combinations
granted -
US 11655288
Antibodies to oxidized phospholipids
granted -
US 11649237
Substituted imidazo[1,5-a]pyrazines for IRE1 inhibition
granted -
US 11648237
5HT agonists for treating disorders
granted -
US 11642410
Targeting microbubbles
granted -
US 11642379
Hematopoietic stem cell engraftment
granted -
US 11643388
Inhibitors of alpha 2 beta 1 integrin and methods of use thereof
granted -
US 11634730
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted